No abstract available
MeSH terms
-
Arteriosclerosis / drug therapy*
-
Biological Availability
-
Cardiovascular Diseases / drug therapy*
-
Cyclooxygenase Inhibitors / adverse effects
-
Cyclooxygenase Inhibitors / pharmacokinetics
-
Cyclooxygenase Inhibitors / therapeutic use*
-
Half-Life
-
Humans
-
Hypertension / drug therapy*
-
Prostaglandin-Endoperoxide Synthases / metabolism
-
Prostaglandin-Endoperoxide Synthases / physiology*
-
Thrombosis / chemically induced
Substances
-
Cyclooxygenase Inhibitors
-
Prostaglandin-Endoperoxide Synthases